Publications by authors named "Ernst Bohnlein"

Claim this Profile
F
Full-length merozoite surface protein 1 formulated with GLA-SE adjuvant in malaria pre-exposed adults: a randomised, controlled, double-blind, parallel-group, single-centre Phase Ib trial.
Aina-Ekisha Kahatano, Maxmillian Mpina, Fiona Vanobberghen, Omary Hassan, Nsiande Urasa

EClinicalMedicine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine.
Micha Rosenkranz, Kristin Fürle, Julia Hibbert, Anne Ulmer, Arin Ali

NPJ Vaccines· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization with full-length merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial.
Antje Blank, Kristin Fürle, Anja Jäschke, Gerd Mikus, Monika Lehmann

NPJ Vaccines· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of drug and cell-based delivery: engineered adult mesenchymal stem cells expressing soluble tumor necrosis factor receptor II prevent arthritis in mouse and rat animal models.
Linda N Liu, Gang Wang, Kyle Hendricks, Keunmyoung Lee, Ernst Bohnlein

Stem Cells Transl Med· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis